MADRIGAL PHARMACEUTICALS INC (MDGL)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for MDGL
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| MDGL | Independent Chairman of the Board of Directors and Class I Director | 59 | ["Managing Member of Baker Bros. Advisors LP","Experience investing in life sciences companies","Experience serving on board of directors of other public companies in the life sciences industry"] | ["Audit","Compensation"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ACAD | Director | 59 | [] | [] | 2026 |
| INCY | Chair of the Board | 59 | ["Managing Member of Baker Bros. Advisors LP","experienced investor in life sciences companies","significant strategic and financial expertise","extensive knowledge of the life sciences and biopharmaceuticals industries"] | ["Nominating and Corporate Governance","Compensation","Nominating and Corporate Governance Committee"] | 2026 |
| DNLI | Director | 58 | [] | [] | 2025 |
Biography sourced from the proxy statement filing.
Managing Member of Baker Bros. Advisors LP (BBA), a biotechnology-focused investment advisor to fund partnerships whose investors are primarily endowments and foundations. Founded BBA, together with his brother Felix Baker, in 2000. Portfolio manager at Tisch Financial Management from 1994 to 1999, prior to BBA. Employed by the private equity investment arm of Credit Suisse First Boston Corporation from 1988 to 1993. Previously served on the board of directors of Alumis, Inc. from January 2022 to June 2024 and Prelude Therapeutics Inc. (Prelude) from January 2021 to June 2025. Mr. Baker holds an A.B. from Harvard University. Other Company Board Service Mr. Baker serves on the board of directors of the following publicly traded companies: Incyte Corporation (Incyte) since November 2001 Acadia Pharmaceuticals, Inc. (Acadia) since December 2015 Denali Therapeutics Inc. since June 2025 Qualifications We believe that Mr. Baker is qualified to serve on our Board due to his experience investing in many life sciences companies, as well as his experience serving on the board of directors of other public companies in the life sciences industry.